IDEAS home Printed from https://ideas.repec.org/a/bla/biomet/v57y2001i4p1089-1095.html
   My bibliography  Save this article

Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology

Author

Listed:
  • Nigel Stallard
  • Peter F. Thall

Abstract

No abstract is available for this item.

Suggested Citation

  • Nigel Stallard & Peter F. Thall, 2001. "Decision-Theoretic Designs for Pre-Phase II Screening Trials in Oncology," Biometrics, The International Biometric Society, vol. 57(4), pages 1089-1095, December.
    • Handle: RePEc:bla:biomet:v:57:y:2001:i:4:p:1089-1095
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1111/j.0006-341X.2001.01089.x
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Nigel Stallard & Peter F. Thall & John Whitehead, 1999. "Decision Theoretic Designs for Phase II Clinical Trials with Multiple Outcomes," Biometrics, The International Biometric Society, vol. 55(3), pages 971-977, September.
    2. Ying Kuen Cheung & Rick Chappell, 2000. "Sequential Designs for Phase I Clinical Trials with Late-Onset Toxicities," Biometrics, The International Biometric Society, vol. 56(4), pages 1177-1182, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Nigel Stallard, 2003. "Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies," Biometrics, The International Biometric Society, vol. 59(2), pages 402-409, June.
    2. Peter F. Thall & Hoang Q. Nguyen & Sarah Zohar & Pierre Maton, 2014. "Optimizing Sedative Dose in Preterm Infants Undergoing Treatment for Respiratory Distress Syndrome," Journal of the American Statistical Association, Taylor & Francis Journals, vol. 109(507), pages 931-943, September.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Erica Brittain & Dean Follmann & Song Yang, 2008. "Dynamic Comparison of Kaplan–Meier Proportions: Monitoring a Randomized Clinical Trial with a Long-Term Binary Endpoint," Biometrics, The International Biometric Society, vol. 64(1), pages 189-197, March.
    2. Yifei Zhang & Sha Cao & Chi Zhang & Ick Hoon Jin & Yong Zang, 2021. "A Bayesian adaptive phase I/II clinical trial design with late‐onset competing risk outcomes," Biometrics, The International Biometric Society, vol. 77(3), pages 796-808, September.
    3. Lurdes Y. T. Inoue & Peter F. Thall & Donald A. Berry, 2002. "Seamlessly Expanding a Randomized Phase II Trial to Phase III," Biometrics, The International Biometric Society, vol. 58(4), pages 823-831, December.
    4. Thomas M. Braun, 2018. "Motivating sample sizes in adaptive Phase I trials via Bayesian posterior credible intervals," Biometrics, The International Biometric Society, vol. 74(3), pages 1065-1071, September.
    5. Changying A. Liu & Thomas M. Braun, 2009. "Parametric non‐mixture cure models for schedule finding of therapeutic agents," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 58(2), pages 225-236, May.
    6. B. Nebiyou Bekele & Yisheng Li & Yuan Ji, 2010. "Risk-Group-Specific Dose Finding Based on an Average Toxicity Score," Biometrics, The International Biometric Society, vol. 66(2), pages 541-548, June.
    7. Nadine Houede & Peter F. Thall & Hoang Nguyen & Xavier Paoletti & Andrew Kramar, 2010. "Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials," Biometrics, The International Biometric Society, vol. 66(2), pages 532-540, June.
    8. Sambucini, Valeria, 2019. "Bayesian predictive monitoring with bivariate binary outcomes in phase II clinical trials," Computational Statistics & Data Analysis, Elsevier, vol. 132(C), pages 18-30.
    9. Ying Kuen Cheung & Peter F. Thall, 2002. "Monitoring the Rates of Composite Events with Censored Data in Phase II Clinical Trials," Biometrics, The International Biometric Society, vol. 58(1), pages 89-97, March.
    10. Alessandra Giovagnoli, 2021. "The Bayesian Design of Adaptive Clinical Trials," IJERPH, MDPI, vol. 18(2), pages 1-15, January.
    11. Anastasia Ivanova & Se Hee Kim, 2009. "Dose Finding for Continuous and Ordinal Outcomes with a Monotone Objective Function: A Unified Approach," Biometrics, The International Biometric Society, vol. 65(1), pages 307-315, March.
    12. Ying Kuen Cheung, 2002. "On the Use of Nonparametric Curves in Phase I Trials with Low Toxicity Tolerance," Biometrics, The International Biometric Society, vol. 58(1), pages 237-240, March.
    13. Yuan Ji & B. Nebiyou Bekele, 2009. "Adaptive Randomization for Multiarm Comparative Clinical Trials Based on Joint Efficacy/Toxicity Outcomes," Biometrics, The International Biometric Society, vol. 65(3), pages 876-884, September.
    14. Ying Yuan & Guosheng Yin, 2009. "Bayesian dose finding by jointly modelling toxicity and efficacy as time‐to‐event outcomes," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 58(5), pages 719-736, December.
    15. Tianjian Zhou & Wentian Guo & Yuan Ji, 2020. "PoD-TPI: Probability-of-Decision Toxicity Probability Interval Design to Accelerate Phase I Trials," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 12(2), pages 124-145, July.
    16. Ying Kuen Cheung & Rick Chappell, 2002. "A Simple Technique to Evaluate Model Sensitivity in the Continual Reassessment Method," Biometrics, The International Biometric Society, vol. 58(3), pages 671-674, September.
    17. Nigel Stallard, 2003. "Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies," Biometrics, The International Biometric Society, vol. 59(2), pages 402-409, June.
    18. Thomas M. Braun & Zheng Yuan & Peter F. Thall, 2005. "Determining a Maximum-Tolerated Schedule of a Cytotoxic Agent," Biometrics, The International Biometric Society, vol. 61(2), pages 335-343, June.
    19. Steffen Ventz & Lorenzo Trippa, 2015. "Bayesian designs and the control of frequentist characteristics: A practical solution," Biometrics, The International Biometric Society, vol. 71(1), pages 218-226, March.
    20. Gerlinger, Christoph & Siedentop, Harald & Gerke, Oke & Schellschmidt, Ilka & Endrikat, Jan, 2012. "Optimal dose de-escalation trial designs for novel contraceptives in women," Computational Statistics & Data Analysis, Elsevier, vol. 56(5), pages 1061-1068.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:biomet:v:57:y:2001:i:4:p:1089-1095. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0006-341X .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.